These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2742727)

  • 1. Plasma debrisoquin levels in the assessment of reduction of plasma homovanillic acid. The debrisoquin method.
    Riddle MA; Jatlow PI; Anderson GM; Cho SC; Hardin MT; Cohen DJ; Leckman JF
    Neuropsychopharmacology; 1989 Jun; 2(2):123-9. PubMed ID: 2742727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief debrisoquin administration to assess central dopaminergic function in children.
    Riddle MA; Shaywitz BA; Leckman JF; Anderson GM; Shaywitz SE; Hardin MT; Ort SI; Cohen DJ
    Life Sci; 1986 Mar; 38(11):1041-8. PubMed ID: 3456480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.
    Riddle MA; Leckman JF; Cohen DJ; Anderson M; Ort SI; Caruso KA; Shaywitz BA
    J Neural Transm; 1986; 67(1-2):31-43. PubMed ID: 3465864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's disease.
    Rose S; Hindmarsh JG; Steiger MJ; Bhatt M; Quinn NP; Jenner P; Marsden CD
    Clin Neuropharmacol; 1994 Jun; 17(3):260-9. PubMed ID: 9316671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M; Losonczy MF; Mohs RC; Lesser JC; Powchik P; Freed LB; Davis BM; Mykytyn VV; Davis KL
    Neuropsychopharmacology; 1987 Dec; 1(1):17-23. PubMed ID: 3509064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homovanillic acid as an index of brain dopamine metabolism: enhancement with debrisoquin.
    Sternberg DE; Heninger GR; Roth RH
    Life Sci; 1983 May; 32(21):2447-52. PubMed ID: 6855448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-free homovanillic acid: within- and across-day stability in children and adults with Tourette's syndrome.
    Riddle MA; Leckman JF; Anderson GM; Ort SI; Hardin MT; Stevenson J; Cohen DJ
    Life Sci; 1987 Jun; 40(22):2145-51. PubMed ID: 3473273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of debrisoquin on CSF and plasma HVA concentrations in man.
    Maas JW; Contreras SA; Bowden CL; Weintraub SE
    Life Sci; 1985 Jun; 36(22):2163-70. PubMed ID: 3999921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of dopaminergic function in children and adults: long and brief debrisoquin administration combined with plasma homovanillic acid.
    Riddle MA; Leckman JF; Anderson GM; Hardin MT; Ort SI; Towbin KE; Shaywitz BA; Cohen DJ
    Psychopharmacol Bull; 1987; 23(3):411-4. PubMed ID: 3481088
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP.
    Kopin IJ; Bankiewicz KS; Harvey-White J
    Neuropsychopharmacology; 1988 May; 1(2):119-25. PubMed ID: 3266957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.
    Maas JW; Contreras SA; Seleshi E; Bowden CL
    Arch Gen Psychiatry; 1988 Jun; 45(6):553-9. PubMed ID: 3377641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dopamine agonists on plasma and brain levels of homovanillic acid.
    Kendler KS; Heninger GR; Roth RH
    Life Sci; 1982 Jun; 30(24):2063-9. PubMed ID: 7109836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach to biochemical evaluation of brain dopamine metabolism.
    Kopin IJ; White JH; Bankiewicz K
    Cell Mol Neurobiol; 1988 Jun; 8(2):171-9. PubMed ID: 3044592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.
    Konicki PE; Owen RR; Litman RE; Pickar D
    Life Sci; 1991; 48(14):1411-6. PubMed ID: 2008157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mental stress on plasma homovanillic acid in healthy human subjects.
    Sumiyoshi T; Yotsutsuji T; Kurachi M; Itoh H; Kurokawa K; Saitoh O
    Neuropsychopharmacology; 1998 Jul; 19(1):70-3. PubMed ID: 9608578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients.
    Pickar D; Breier A; Kelsoe J
    Ann N Y Acad Sci; 1988; 537():339-46. PubMed ID: 2904783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain contribution to the haloperidol-induced increase in plasma homovanillic acid.
    Kendler KS; Heninger GR; Roth RH
    Eur J Pharmacol; 1981 May; 71(2-3):321-6. PubMed ID: 7250191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ceruletide on plasma monoamine metabolites in the rabbit.
    Wakata N; Kawamura Y; Kobayashi M; Sumiyoshi S; Okada K; Kinoshita M
    J Neurol Sci; 1991 May; 103(1):97-100. PubMed ID: 1713954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homovanillic acid in untreated schizophrenia--relationship with symptomatology and sex.
    Zhang ZJ; Peet M; Ramchand CN; Shah S; Reynolds GP
    J Psychiatr Res; 2001; 35(1):23-8. PubMed ID: 11287053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.